Switch to:
GuruFocus has detected 5 Warning Signs with PDL BioPharma Inc \$PDLI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
PDL BioPharma Inc (NAS:PDLI)
EV-to-Revenue
1.50 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, PDL BioPharma Inc's enterprise value is \$367.1 Mil. PDL BioPharma Inc's revenue for the trailing twelve months (TTM) ended in Dec. 2016 was \$244.3 Mil. Therefore, PDL BioPharma Inc's EV/Revenue ratio for today is 1.50.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, PDL BioPharma Inc's stock price is \$2.25. PDL BioPharma Inc's revenue per share for the trailing twelve months (TTM) ended in Dec. 2016 was \$1.49. Therefore, PDL BioPharma Inc's P/S Ratio for today is 1.51.

Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

PDL BioPharma Inc's EV/Revenue for today is calculated as:

 EV/Revenue = Enterprise Value (Today) / Revenue (TTM) = 367.089 / 244.301 = 1.50

PDL BioPharma Inc's current Enterprise Value is \$367.1 Mil.
PDL BioPharma Inc's Revenue for the trailing twelve months (TTM) ended in Dec. 2016 was 103.124 (Mar. 2016 ) + 21.047 (Jun. 2016 ) + 53.638 (Sep. 2016 ) + 66.492 (Dec. 2016 ) = \$244.3 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

PDL BioPharma Inc's P/S Ratio for today is calculated as:

 P/S Ratio = Share Price (Today) / Revenue Per Share (TTM) = 2.25 / 1.488 = 1.51

PDL BioPharma Inc's share price for today is \$2.25.
PDL BioPharma Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Dec. 2016 was 0.629 (Mar. 2016 ) + 0.128 (Jun. 2016 ) + 0.326 (Sep. 2016 ) + 0.405 (Dec. 2016 ) = \$1.49.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

PDL BioPharma Inc Annual Data

 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 ev2rev 9.03 3.72 3.91 3.30 2.94 3.01 3.26 2.42 1.04 1.41

PDL BioPharma Inc Quarterly Data

 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 ev2rev 2.44 2.42 2.13 1.95 1.75 1.04 0.90 1.49 1.70 1.41
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)